Loading...

Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment Strategy

Treatment with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) improves the overall survival of patients with EGFR-mutated non-small-cell lung cancer (NSCLC). First-generation EGFR-TKIs (e.g., gefitinib and erlotinib) or second-generation EGFR-TKIs (e.g., afatinib and dacomit...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cells
Main Authors: Nagano, Tatsuya, Tachihara, Motoko, Nishimura, Yoshihiro
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6262543/
https://ncbi.nlm.nih.gov/pubmed/30445769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells7110212
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!